📈 From Gold to Growth: What Investors Are Watching Now
After a multi-week rally that’s seen gold hover near historic highs, the yellow metal is still catching bids—especially as volatility persists in global markets.
From Gold to Growth: What Investors Are Watching Now
Markets may be catching their breath, but the undercurrents remain active. With U.S.-China tariff chatter cooling (for now) and Beijing carving out key exemptions, investors are parsing the signals. At the same time, gold continues to hold investor attention, with mining stocks finding fresh support as safe-haven appetite lingers.
Meanwhile, headlines from Hudson’s Bay’s final chapter to crypto firm Circle’s IPO plans reflect a market balancing legacy fades with new frontiers. In biotech, clinical momentum keeps building, and across the board, companies are repositioning for the next wave.
Whether you’re leaning into commodities, watching for IPO openings, or following pharma’s latest milestones, there’s no shortage of moves to track.
Stay sharp with B-TV’s latest feature.
Visit www.b-tv.com for exclusive updates and breaking news, helping you make informed investment decisions before the rest of the market catches on.
Let’s see where the markets take us next.
3 Minute Read:
Here's how some major markets/indexes performed in the last 5-days:
- Dow Jones: 39,999 (2.81%)
- Nasdaq 100: 19,349 (7.36%)
- TSX: 24,635 (1.93%)
- BTC: 94,836 (0.95%)
- Ethereum: 1,794 (13.08%)
(USD)
As of 04/25/2025 at 11:00PM PST
China Eases a Bit on Tariffs
Despite ruling out formal trade negotiations, China has taken a step back by exempting some U.S. goods from its 125 percent retaliatory tariffs. Pharmaceuticals and aerospace supplies are among the products excluded, and Chinese authorities are inviting businesses to submit lists of other critical imports they believe should also be tariff-free.
Why it matters: While this does not mark a shift toward a new trade deal, it may indicate an interest in keeping certain economic channels open. For investors, it suggests that even amid high tensions, essential industries could remain somewhat insulated from the broader trade fallout.
Premier American Uranium (TSX.V: PUR, OTCQB: PAUIF) is developing assets in key U.S. uranium districts to support the rising global need for nuclear fuel.
Sitka Gold (CSE: SIG, OTCQB: SITKF) is expanding its gold resource in the Yukon with a fully funded 30,000-meter drill program and a multi-million-ounce gold estimate already in hand.
Cascadia Minerals (TSX.V: CAM) is exploring uncharted copper-gold terrain in the Yukon’s Stikine Terrane, with new high-grade discoveries and a fully funded drill program planned for 2025.
Gold Holds the Spotlight, Silver Joins the Show
After a multi-week rally that’s seen gold hover near historic highs, the yellow metal is still catching bids—especially as volatility persists in global markets. Miners are feeling the tailwind, too. According to Morningstar, high gold prices are strengthening balance sheets and boosting confidence across the sector.
Silver, meanwhile, is playing a different tune. While gold dipped recently, silver prices have quietly moved higher, defying their usual tight correlation. Analysts suggest silver hasn’t yet caught the same monetary premium that’s driving gold’s surge, but that could change fast.
Why it matters: Gold continues to prove its role as a store of value, while silver may be gearing up for its own moment. For investors, the diverging paths of these two metals offer a chance to rethink exposure—especially as central banks keep adding gold and macro uncertainty lingers.
📢 This Week's Selected Company News:
Hudson’s Bay to Wind Down Final Six Stores
The end of an era is drawing closer. Hudson’s Bay Co. is reportedly set to begin liquidation sales at its last six remaining department stores in Canada, marking a historic exit from brick-and-mortar retail. The closures are expected to begin in the coming weeks, as the retailer continues shifting focus to its luxury and e-commerce divisions.
Medicus Pharma Advances SKNJCT-003 Clinical Study
Medicus Pharma has provided an update on its Phase 2 clinical study for SKNJCT-003, targeting the treatment of nodular basal cell carcinoma (BCC). Patient enrollment continues, with preliminary results expected later this year. The study aims to offer a less invasive treatment alternative for one of the most common forms of skin cancer.
Circle Moves Toward Public Markets with IPO Filing
Stablecoin issuer Circle, the company behind USDC, has officially filed for an initial public offering as it looks to capitalize on renewed investor interest in the crypto space. The move signals growing confidence in the sector’s long-term potential as public markets continue to reopen to digital asset companies.
📬 That’s a wrap for this week!
Want more? Visit www.b-tv.com and subscribe for breaking updates, company features, and actionable insights straight from the market’s front lines.
What sector are you interested in? BTV wants to know! Send your thoughts here!
Looking forward to hearing from you!
Until next time!
